Key facts
- ACT Medical’s last known valuation is $3.7M (May 2023).
- It has raised $1.9M; the latest was Angel (individual) ($630K) in Jan 2025.
- Notable investors include Tampa Bay Wave, Accelerate Cambridge, James Dyson Foundation, Royal Academy of Engineering, SantanderX.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for ACT Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for ACT Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ACT Medical
Operator of a medical technology company intended to revolutionize the standard of care for penetrative trauma and reduce the mortality rates associated with violent crime. The company is developing a device that can be inserted into knife and gunshot wounds to reduce catastrophic blood loss, enabling medical first responders to implement better responses for penetrating wounds.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2021
- Employees
- 5
- Website
- actmedical.co.uk/
- Ownership
- Privately Held (backing)
ACT Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ACT Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ACT Medical in its N-PORT filings yet. We sweep new filings monthly.